Most sold healthcare stocks in Q3 2013

See which Healthcare stocks institutional investors trimmed or exited the most in Q3 2013, measured as net reductions in reported share positions from Q2 2013 into Q3 2013. Notable reductions at the top of this list include BOSTON SCIENTIFIC CORP (BSX), BRISTOL-MYERS SQUIBB CO (BMY), ELI LILLY & CO (LLY), TEVA PHARMACEUTICAL-SP ADR (TEVA). These rankings aggregate SEC 13F filings from all institutional investors in our database.

Net change in reported shares (all institutional filers) by symbol20 symbols with net change in reported shares from all institutional filers.−31.0M−23.3M−15.5M−7.8M0.00Net change in reported shares (all institutional filers)BSXBMYLLYTEVAPFEISRGPHGTMOMRKCYHRVTYBIIBGERNAMGNVNDAMASIJNJDHROSURSRPTSymbol
SymbolNameNet sharesNet valueNewAddedTrimmedSold outHolding now
BSXBOSTON SCIENTIFIC CORP-28,189,193-$112.19M00313
BMYBRISTOL-MYERS SQUIBB CO-4,291,638-$184.18M00506
LLYELI LILLY & CO-3,584,614-$165.06M21306
TEVATEVA PHARMACEUTICAL-SP ADR-2,853,952-$112.79M02024
PFEPFIZER INC-2,845,421-$20.58M037014
ISRGINTUITIVE SURGICAL INC-2,670,176-$1.46B12134
PHGKONINKLIJKE PHILIPS NVR- NY-2,249,385$108.31M01203
TMOTHERMO FISHER SCIENTIFIC INC-1,924,865-$7.41M02518
MRKMERCK & CO. INC.-1,492,346-$7.25M125012
CYHCOMMUNITY HEALTH SYSTEMS INC-1,292,600-$63.08M01011
RVTYREVVITY INC-1,153,403-$9.89M00304
BIIBBIOGEN INC-1,128,109-$226.20M01304
GERNGERON CORP-1,091,582$3.18M00202
AMGNAMGEN INC-1,073,398-$99.54M20406
VNDAVANDA PHARMACEUTICALS INC-1,072,529-$7.93M00111
MASIMASIMO CORP-1,043,665-$8.80M00202
JNJJOHNSON & JOHNSON-1,014,781$38.77M099021
DHRDANAHER CORP-780,712$19.90M01103
OSURORASURE TECHNOLOGIES INC-676,500-$1.54M00101
SRPTSAREPTA THERAPEUTICS INC-668,175-$25.42M00010
MOHMOLINA HEALTHCARE INC-588,100-$24.18M00101
AZNASTRAZENECA PLC-SPONS ADR-511,900-$10.72M00101
CNCCENTENE CORP-500,000-$24.38M00101
BAXBAXTER INTERNATIONAL INC-430,405-$58.00M03408
SNYSANOFI-ADR-402,549-$65.88M02309
CCRNCROSS COUNTRY HEALTHCARE INC-391,710-$941.00K00202
ZBHZIMMER BIOMET HOLDINGS INC-329,312-$10.17M01508
BDXBECTON DICKINSON AND CO-296,161-$20.20M11619
AAGILENT TECHNOLOGIES INC-291,786$50.68M01314
CAHCARDINAL HEALTH INC-281,594$1.67M11114
CRLCHARLES RIVER LABORATORIES-262,645$9.27M01103
DGXQUEST DIAGNOSTICS INC-245,312-$13.78M02205
BRKRBRUKER CORP-228,500-$1.87M00101
IDXXIDEXX LABORATORIES INC-223,752-$18.85M00102
SEMSELECT MEDICAL HOLDINGS CORP-191,999-$1.57M00010
AMNAMN HEALTHCARE SERVICES INC-178,200-$2.75M00101
THCTENET HEALTHCARE CORP-174,800-$9.28M00101
HCSGHEALTHCARE SERVICES GROUP-152,100-$3.64M00101
UTHRUNITED THERAPEUTICS CORP-149,600-$4.10M00101
ALKSALKERMES PLC-133,000-$546.00K00101
EBSEMERGENT BIOSOLUTIONS INC-94,200$1.68M01102
OMEROMEROS CORP-82,281-$415.00K00010
CDXSCODEXIS INC-74,800-$203.00K00101
INCYINCYTE CORP-58,100$149.00K00102
OMCLOMNICELL INC-57,943-$1.19M00010
ATRAPTARGROUP INC-57,100-$3.08M00011
STXSSTEREOTAXIS INC-48,842-$76.00K00010
AORTARTIVION INC-44,800-$125.00K00101
MTDMETTLER-TOLEDO INTERNATIONAL-40,800-$8.21M00010
TBRGTRUBRIDGE INC-40,800-$1.46M00101

Frequently asked questions about Most sold healthcare stocks in Q3 2013

  • What are the most sold Healthcare stocks in Q3 2013?

    The most sold healthcare stocks in Q3 2013 are those with the largest decrease in reported share counts across institutional investors compared to Q2 2013, based on SEC 13F filings.

  • Which healthcare stocks did institutional investors trimmed or exited the most in Q3 2013?

    Among filers in this sector, net reductions were largest in companies such as BOSTON SCIENTIFIC CORP (BSX), BRISTOL-MYERS SQUIBB CO (BMY), ELI LILLY & CO (LLY), based on aggregated 13F data.

  • How is institutional selling calculated?

    Selling is calculated by summing the net decrease in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q2 2013).

  • Does this include all institutional owners?

    Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.

  • Are these trades real-time?

    No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.